| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |